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Host Langerin (CD207) is a receptor for Yersinia pestis
phagocytosis and promotes dissemination
Kun Yang1, Chae G Park2, Cheolho Cheong3, Silvia Bulgheresi4, Shusheng Zhang5, Pei Zhang5, Yingxia He1,
Lingyu Jiang1, Hongping Huang6, Honghui Ding1, Yiping Wu7, Shaogang Wang8, Lin Zhang9, Anyi Li10,
Lianxu Xia11, Sara S Bartra12, Gregory V Plano12, Mikael Skurnik13, John D Klena14 and Tie Chen1
Yersinia pestis is a Gram-negative bacterium that causes plague. After Y. pestis overcomes the skin barrier, it encounters
antigen-presenting cells (APCs), such as Langerhans and dendritic cells. They transport the bacteria from the skin to the lymph
nodes. However, the molecular mechanisms involved in bacterial transmission are unclear. Langerhans cells (LCs) express
Langerin (CD207), a calcium-dependent (C-type) lectin. Furthermore, Y. pestis possesses exposed core oligosaccharides. In this
study, we show that Y. pestis invades LCs and Langerin-expressing transfectants. However, when the bacterial core
oligosaccharides are shielded or truncated, Y. pestis propensity to invade Langerhans and Langerin-expressing cells decreases.
Moreover, the interaction of Y. pestis with Langerin-expressing transfectants is inhibited by puriﬁed Langerin, a DC-SIGN
(DC-speciﬁc intercellular adhesion molecule 3 grabbing nonintegrin)-like molecule, an anti-CD207 antibody, puriﬁed core
oligosaccharides and several oligosaccharides. Furthermore, covering core oligosaccharides reduces the mortality associated with
murine infection by adversely affecting the transmission of Y. pestis to lymph nodes. These results demonstrate that direct
interaction of core oligosaccharides with Langerin facilitates the invasion of LCs by Y. pestis. Therefore, Langerin-mediated
binding of Y. pestis to APCs may promote its dissemination and infection.
Immunology and Cell Biology (2015) 93, 815–824; doi:10.1038/icb.2015.46
Yersinia pestis, a Gram-negative bacterium, is the causative agent of
bubonic plague, passed into the annals of history as Black Death
epidemics.1,2 A hallmark of plague is the rapid dissemination of
Y. pestis, which leads to systemic infection in susceptible
individuals.3,4
Many Gram-negative bacterial pathogens contain lipopolysacchar-
ides, which consist of three structural regions: (i) the lipid A backbone,
(ii) core oligosaccharides, and (iii) the O-antigen (Figure 1). Gram-
negative bacteria are classiﬁed as smooth or rough based on the
presence or absence of the O-antigen, respectively. Rough Gram-
negative bacteria bear a shortened lipopolysaccharides—referred to as
lipooligosaccharides (LOS)—of which the oligosaccharide core is
exposed to the extracellular environment.
Innate immune system functions are initiated in the skin by
antigen-presenting cells (APCs) such as dendritic cells (DCs), or a
subset of immature APCs,5,6 such as Langerhans cells (LCs). APCs
either phagocytose and kill invading pathogens or deliver the
pathogens to other types of host immune cells for further elimination.
APCs in the skin express at least three immunoreceptors that belong
to the calcium-dependent (C-type) lectin family: DC-speciﬁc
intercellular adhesion molecule 3 grabbing nonintegrin (DC-SIGN,
CD209), DEC-205 (CD205), and Langerin (CD207). Human LCs
(hLCs) mostly express Langerin but do not express DC-SIGN.7
Pathogens such as HIV exploit DC-SIGN-mediated uptake by APCs
to efﬁciently disseminate throughout a host, travelling to the host’s
lymph nodes.8,9 On the other hand, human Langerin (hLangerin;
CD207), an innate immune receptor for HIV-1 on LCs, may function
as a natural barrier to the transmission of HIV-1 and certain
viruses.10–12
In this study, we investigated the interaction between Langerin and
Y. pestis core oligosaccharides. Our results suggest that after over-
coming the ﬁrst line of host defence (the skin) via a ﬂeabite, Y. pestis
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may exploit LCs to spread throughout the host and consequently may
trigger bacterial dissemination and infection.
RESULTS
Y. pestis invades LCs
One of the mechanisms by which Y. pestis invades human DCs
involves its naturally exposed core oligosaccharides13 and plasminogen
activator.9 The expression of O-antigen shields bacterial core oligo-
saccharides and blocks the interaction of Y. pestis, as well as several
other Gram-negative bacteria, with DCs.13–16 In light of these ﬁndings,
we assessed whether Y. pestis strains KIM10− (rough strain, exposed
core oligosaccharides), KIM10−-O+ (smooth strain, core oligosacchar-
ides covered with an O-polysaccharide) and KIM10−-core− (deep
rough strain, expressing a truncated LOS outer core) could invade
hcbLCs (human cord blood LCs) and hLCs (primary LCs) in a
manner similar to hDCs.13 We used three corresponding Escherichia
coli K-12 strains, CS180 (rough strain, exposed core oligosaccharides),
CS1861 (smooth strain, CS180 expressing an O-antigen) and CS2429
(deep rough strain, outer core oligosaccharides deleted) as controls.
These E. coli strains have been used previously to demonstrate that the
exposure of the E. coli core oligosaccharides is essential for bacterial
interaction with DC-SIGN (Table 1).13–16 Both the Y. pestis and E. coli
rough strains (KIM10− and CS180), but not the corresponding
smooth strains (KIM10−-O+ and CS1861) or the corresponding deep
rough strains (KIM10−-core− and CS2429) effectively invaded hcbLCs
and hLCs, suggesting that bacterial uptake is mediated by their core
oligosaccharides (Figure 2).
Y. pestis invades Chinese hamster ovary (CHO) cells that express
Langerin
Whereas LCs do not express DC-SIGN,7 the C-type lectin Langerin is
one of their major receptors. Therefore, we tested whether the ability of
Y. pestis to invade hcbLCs and hLCs depended on the bacterium’s
interaction with Langerin. The same Y. pestis (KIM10−, KIM10−-O+ and
KIM10−-core−) and E. coli strains (CS180, CS1861 and CS2429) were
tested for their ability to invade CHO transfectants stably expressing two
C-type lectin receptors, CHO-hLangerin and CHO-hDEC-205 (human
CD205) (Figure 3a). We selected hDEC-205 because recent data have
shown that murine DEC-205 serves as the receptor for plasminogen
activator of Y. pestis.9 We used CHO-NEO as a control-transfected cell
line, as it expresses only the neomycin gene. The results show that the
rough Y. pestis strain KIM10− invades CHO-hLangerin cells, but not
CHO-NEO and CHO-hDEC-205 cells, indicating that hLangerin is a
receptor for Y. pestis (Figure 3b). In addition, the rough strains KIM10−
and CS180 but neither the smooth strains (KIM10−-O+ or CS1861) nor
the deep rough strains (KIM10−-core− or CS2429) promoted the
invasion of CHO-hLangerin cells, indicating that core oligosaccharides
of both Y. pestis and E. coli K-12 are ligands for hLangerin. Of note,
hDC-SIGN displayed a similar ability to bind the bacterial core
oligosaccharides.13–16
The core oligosaccharides of E. coli mediate the interaction with
hLangerin
Although the data shown in Figures 2 and 3 suggest that Y. pestis
utilises its core oligosaccharides as a ligand to interact with hcbLCs,
hLCs and hLangerin-expressing cells, we cannot exclude the possibility
that another outer membrane component may function as an
additional ligand. The O-antigen may indeed prevent access to many
of the surface structures that are exposed in the rough E. coli and
Y. pestis mutants. For example, recent data from our lab have
demonstrated that the expression of O-antigen blocks the interaction
of murine DEC-205 (mCD205, another receptor for Y. pestis) with
plasminogen activator.9,17 Although core oligosaccharide mutants of
Y. pestis are not presently available, well-characterised core oligosac-
charide mutants of E. coli, Salmonella and Neisseria gonorrhoeae have
been used to demonstrate that Gram-negative bacteria use core
oligosaccharide components to interact with hDC-SIGN.14 Therefore,
we examined the abilities of several E. coli core oligosaccharide
mutants (waaR, waaO, waaG and waaC) (Figure 1) to interact with
CHO-hLangerin cells (Table 1). Figure 4 shows that the waaR, waaO,
waaG and waaC mutants, which express core oligosaccharides of
decreasing lengths, lose the ability to promote phagocytosis by
CHO-hLangerin cells, suggesting that the epitope recognised by
hLangerin resides in the main chain of the outer LOS core. Although
the waaR, waaO and waaG mutants show increased resistance to
phagocytosis by CHO-hLangerin cells, all three mutants are less
resistant to phagocytosis compared with the waaC mutant, suggesting
that some sugars in the core between the ﬁrst heptose and the
terminus of the LOS core participate in the LOS–Langerin interaction.
The data from the E. coli lipopolysaccharides mutant isolates show
that an outer-core saccharide has an important role in the hLangerin
interaction. This mirrors the data between core oligosaccharides and
hLangerin (Figures 2, 3 and 4) and between core oligosaccharides and
hDC-SIGN.13,14,16
Inhibition of Langerin-mediated phagocytosis of Y. pestis by
puriﬁed FLAG-Langerin, an anti-Langerin antibody, mannan,
oligosaccharides and a DC-SIGN-like molecule
hcbLCs express both hLangerin and hDC-SIGN (Figure 5a). We
examined whether host–pathogen interactions could be inhibited by
anti-hLangerin and anti-hDC-SIGN antibodies in these cells (Table 1).
As shown in Figure 5b, when used individually, neither anti-hLangerin
nor anti-hDC-SIGN antibodies affected the phagocytosis of Y. pestis
KIM10− by hcbLCs. However, when these two antibodies were
combined, the phagocytosis of KIM10− by hcbLCs was signiﬁcantly
reduced. Nevertheless, this reduction was not complete, suggesting
Figure 1 Structures of the inner-core and outer-core regions of the core
oligosaccharides of E. coli K-12 and Y. pestis and the genes involved in
their synthesis. Genes encoding enzymes that are involved in the
biosynthesis of core oligosaccharides are shown along with lines that
indicate the approximate sites at which the enzymes exert their activity (solid
line). Sites that are variably substituted or still under investigation are
indicated by dashed lines. GlcNAc, N-acetyl-glucosamine; Glc, glucose; Hep,
heptose; Gal, galactose; P, phosphate; PPEtn, phosphoethanolamine; KDO,
2-keto-3-deoxyoctonate. Y. pestis and E. coli K-12 naturally do not possess
O-antigens.
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that additional receptors for Y. pestis are present on the hcbLCs
(Figure 5b).
Primary hLCs predominantly express hLangerin (Figure 5c) and an
anti-Langerin antibody was indeed sufﬁcient to inhibit Y. pestis
phagocytosis by hLCs (Figure 5d). This suggests that the hLangerin
receptor has a major role in the interaction between LCs and
Y. pestis.
Puriﬁed FLAG-Langerin, mannan (an antagonist of mannose
receptors), several oligosaccharides, a DC-SIGN-like molecule
(Mermaid) and the anti-hLangerin antibody were tested to determine
whether any of these molecules could block the interaction between
Y. pestis and CHO-hLangerin cells. A speciﬁc set of oligosaccharides
(found in the core oligosaccharides) and a recombinant form of
the C-type lectin Mermaid (His-Mermaid) were selected based on
their ability to inhibit the core oligosaccharide–hDC-SIGN
interaction.13,14,16 Yersinia pseudotuberculosis serotype O:1a (Y1),
which displays a Langerin-independent interaction with epithelial
cells, served as a control strain for the invasion assay. Because of its
strong invasive ablity, only one-third of the bacterial suspension of Y1
was used for infection relative to the rest of strains (Table 1).
Puriﬁed FLAG-Langerin, mannan, several oligosaccharides
(Gal-GalNAc, GlcNAc-Gal-Glc (A8297), Gal-GlcNAc (A7916) and
especially the 3'-Sialyl-Lewis-X tetrasaccharide, (S1782)), His-
Mermaid and one single-sugar residue (GlcNAc) inhibited the
interaction between KIM10− and CHO-hLangerin cells (Figure 5e;
Table 1). In addition, the anti-hLangerin antibody appeared to
inhibit the interaction between KIM10− and CHO-hLangerin cells
compared with the ability of the anti-Langerin antibody to inhibit the
Y. pestis–hLC interaction. The recovery rates of Y1 and KIM10−
bacteria were reduced in the presence of lactoferrin, indicating that
some bacteria are susceptible to the lactoferrin peptide, which is well
known for its antibacterial properties.18
Puriﬁed FLAG-Langerin and DC-SIGN-like molecules bind to
rough but not smooth Y. pestis
Puriﬁed FLAG-Langerin and His-Mermaid have previously been
shown to inhibit the interaction between Y. pestis core oligosaccharides
and hLangerin. To determine whether this inhibition was due to
competition between these two lectins and hLangerin for binding to
core oligosaccharides, the abilities of puriﬁed FLAG-Langerin and
His-Mermaid to bind to KIM10− and KIM10−-O+ were tested. E. coli
strains CS180 and CS1861 were included as positive and negative
controls, respectively, for the His-Mermaid-binding experiments.
Figure 6 shows that puriﬁed ﬂuorescein isothiocyanate (FITC)-
Langerin and FITC-His-Mermaid bind more strongly to KIM10−
and CS180 than to KIM10−-O+ and CS1861, indicating that these
two molecules directly interact with the core oligosaccharides of
Y. pestis.
Table 1 Bacterial strains and cell lines used in this study
Strains Genotypes (phenotypes) References
Y. pestis
KIM6+ Wild type (rough) 37
KIM6+-O+ KIM6+ expressing O-antigen (smooth) 19
KIM10− (KIM10-Δail) Derivative of KIM5 in which the ail gene has been deleted and both plasmid
pCD1 and pPCP1 have been cured
13,38
KIM10−- O KIM10−-O-antigen 19
KIM10−-core− (gmhA-deleted KIM10−) Deep rough mutant derivative of KIM10−, the gmhA allelic exchange
plasmid pCBD41 was
mobilised from E. coli SM10λpir/pCBD41 into KIM10−
This study
Y. pestis 1418 KIM D27 ( Lcr+, pgm−, pst+) 46,47
Y. pestis 1418-O+ Y. pestis 1418 expressing O-antigen (smooth) This study
Y. pseudotuberculosis
Y1 O:1a, wild-type expressing invasin but with pYV plasmid
naturally cured (smooth)
17,48
E. coli K-12
CS180 Wild-type (rough) 35,36,49
CS1861 CS180-O-antigen 35,36,49
CS2429 waaC 35,36,49
CS2198 waaR 35,36,49
CS2488 waaO 35,36,49
CS1943 waaG 35,36,49
Cell lines Characteristics
hcbLCs Langerhans cells derived from human cord blood cells were purchased from MatTek Corporation (Ashland, MA, USA)
hLCs Isolated from skin biopsy samples obtained from healthy patients undergoing plastic surgery
CHO-NEO cells Control cell line, which expresses the neomycin resistance gene only
CHO-hLangerin cells Generated by transfecting CHO cells with human Langerin cDNAs for stable surface expression
CHO-hDEC-205 cells Generated by transfecting CHO cells with human DEC-205 cDNAs for stable surface expression
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Expression of O-antigen reduces the ability of Y. pestis to
disseminate to lymph nodes and delays death in a murine model
We speculated that the interaction of Y. pestis with C-type lectin
receptors promotes bacterial dissemination.9,13 Given that the inter-
action appears to be mediated by core oligosaccharides and hLangerin,
we hypothesised that shielding the exposed core oligosaccharides of
Y. pestis would reduce its dissemination and consequently delay death
in a murine model. To test this hypothesis, the Y. pestis strain KIM6,
as well as the strain KIM D27 with and without O-antigen expression,
were injected into mouse metacarpal paw pads. The KIM6 and KIM
D27 strains were used in this experiment rather than KIM10 because
KIM10 does not survive in mice.9,13 For the dissemination assay,
subiliac lymph nodes were collected, and the bacterial counts were
determined, which allowed for the calculation of Y. pestis dissemina-
tion rates into the lymph nodes. In mice challenged with the strain
KIM D27, the amount of time that the animals took to succumb to
infection was recorded following inoculation. As indicated in Figure 7,
the dissemination (Figure 7a) and death (Figure 7b) of O-antigen-
expressing Y. pestis were signiﬁcantly reduced. Notably, the expression
of O-antigen did not affect Y. pesits infectivity when delivered
Figure 2 Y. pestis core oligosaccharides interact with hcbLCs or hLCs. (a and b) Gentamicin protection and (c and d) ﬂow cytometry assays were used to
determine the invasion rates of two sets of the Gram-negative bacteria Y. pestis (KIM10−, KIM10−-O+ and KIM10−-core−) and E. coli K-12 (CS180, CS1861
and CS2429) into hcbLCs or hLCs. These Y. pestis and E. coli K-12 strains are also described in Zhang et al.13 (a and b) The data presented were pooled
from three independent experiments. The data represent the means± s.e.m. N=9. Statistical analysis was performed using one-way analysis of variance and
the Newman–Keuls test. ***Po0.001. (c and d) Labelled and unlabelled bacteria are indicated by open and ﬁlled symbols, respectively.
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intravenously, indicating that Y. pestis uptake by skin APCs mediate Y.
pesits dissemination.19 In addition, the growth rate of Y. pestis was not
dependent on O-antigen expression.
DISCUSSION
LCs belong to a subset of immature DCs localised in the skin20 and
express the major C-type lectin receptor Langerin instead of
DC-SIGN.7 In this study, using a well-deﬁned set of core oligosac-
charides mutants, we demonstrated that, similar to hDC-SIGN,
hLangerin binds the core oligosaccharides of Y. pestis. This interaction
is likely important for the initiation of Y. pestis pathogenesis in a
manner analogous to HIV-1 infection mechanisms. HIV-1 has been
reported to hijack DC-SIGN to ensure its capture and transmission to
CD4+ lymphocytes target cells located in the lymph nodes.21–23
The interaction of Y. pestis with hDC-SIGN from monocyte-derived
dendritic cells (MDDCs) supports this idea.13 The interaction of
Y. pestis with MDDCs can be reduced by combined treatment with
anti-hDC-SIGN and anti-hLangerin antibodies, suggesting that
hLangerin could act as a redundant receptor for Y. pestis in
MDDCs.13 The commercially available LCs employed in this study
were generated from human cord blood cells and express both
Langerin and, to a lesser extent, DC-SIGN (Figure 5a). These LCs
behaved similarly to MDDCs as a combination of anti-hDC-SIGN and
anti-hLangerin antibodies signiﬁcantly decreased their ability to bind
Y. pestis.13,14
Several Gram-negative bacteria,14–16 including Y. pestis,13 utilise
their exposed core oligosaccharides to interact with hDC-SIGN. The
functional similarity between hLangerin and hDC-SIGN is consistent
with a recent study from Chatwell et al.,24 which showed that the
carbohydrate recognition domain of hLangerin is structurally very
similar to that of hDC-SIGN.
Oligosaccharides were selected based on their predicted ability to
inhibit Y. pestis–C-type lectin interactions.25 Several Gram-negative
bacteria, including Y. pestis, might utilise their core oligosaccharides to
interact with hDC-SIGN.13,14 26 In addition, HIV uses the gp120–DC-
SIGN interaction to initiate capture by DCs and transmission to CD4+
T cells.21 Therefore, blockage of DC-SIGN-mediated transmission of
HIV is recognised as a valid therapeutic strategy to ﬁght HIV infection.
For example, Lewis X oligosaccharides have been shown to prevent
DC-mediated HIV-1 transmission by blocking the DC-SIGN–gp120
interaction.27 Our studies conﬁrm that some oligosaccharides inhibit
the interactions between Y. pestis and transfectants expressing hDC-
SIGN13 or hLangerin (Figure 5). Although Lewis X components do
not interact with hLangerin well, they also inhibit the hLangerin–
Y. pestis interaction (Figure 5e). This may be due to the fact that Lewis
X components may bind both the ligand, the core lipopolysaccharides
on Y. pestis and Langerin-expressing host cells.
HIV surface proteins, such as GP120, are highly glycosylated and
bind to DC-SIGN and Langerin,28 likely via their carbohydrate
moieties. Although extensive biochemical, structural and functional
studies have been performed to understand the interactions between
GP120 and C-type lectin receptors, it remains unclear whether
DC-SIGN and Langerin bind the same sugar residues on GP120.
Given that hDC-SIGN and hLangerin bind the same bacterial
carbohydrate structures of core oligosaccharides from several Gram-
negative bacteria, we speculate that hDC-SIGN and hLangerin might
also bind the same sugar residues on HIV-1 GP120. In contrast to
GP120, the core oligosaccharides are amenable to manipulation,13–16
and thus their analysis may shed light on HIV–host interactions.
Figure 3 Y. pestis invades CHO-hLangerin cells but not other transfectants. The expression levels of each of the CHO transfectants are shown in panel (a),
with the transfectants and CHO-NEO cells represented by open and ﬁlled curves, respectively. The phagocytosis (b) of two sets of bacteria E. coli K-12
(CS180, CS1861 and CS2429) and Y. pestis (KIM10−, KIM10−-O+ and KIM10−-core−) by CHO-hLangerin and CHO-hDEC-205 cells were analysed. Bacteria
and CHO transfectants were incubated together for 2 h, and extracellular bacteria were killed with 100 μgml−1 (ﬁnal concentration) gentamicin. CHO-NEO
cells were used as the negative control cell line. The number of phagocytosed bacteria was determined by counting CFU recovered following gentamicin
treatment. The data presented were pooled from three independent experiments. The data represent the means± s.e.m. N=9. Statistical analysis was
performed using one-way analysis of variance and the Newman–Keuls test. ***Po0.001.
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Most cells that express C-type lectins function in innate
immunity.29,30 Langerin is an innate immune receptor for HIV-1 that
is present on LCs and may function as a natural barrier to the
transmission of HIV-1 and other viruses.10–12 However, the LD50 of
certain strains of Y. pestis, such as CO92, has been reported to be as
low as one colony-forming unit (CFU) in a murine model.31,32 Based
on these observations, it is not surprising that Y. pestis caused the
death of over one-third of the European population during the Black
Death epidemic.33 Therefore, we speculate that the natural barrier
function provided by Langerin against certain viruses does not apply to
dissemination and infection by Y. pestis.
Taken together, this study demonstrates that Langerin is a cellular
receptor for Y. pestis core oligosaccharides and suggests that Langerin-
mediated uptake by APCs may promote bacterial dissemination.
We speculate that Y. pestis may hijack APCs to promote bacterial
transportation to the lymph nodes, employing a mechanism similar to
that of HIV, which has been shown to interact with DC-SIGN. This
acquired knowledge should spur novel strategies to combat Y. pestis
infection by blocking its interaction with host cell receptors.
METHODS
Declaration of ethical approval
All experiments were approved by the Medical Ethics Committee of Tongji
Hospital and were conducted in accordance with the institutional guidelines.
Bacterial strains
E. coli K-12 strain CS180 synthesises core oligosaccharides but lacks an
O-antigen. CS1861 is a derivative of CS180 that harbours pSS37, a plasmid
containing all of the genes necessary for the expression of the Shigella
dysenteriae serotype 1 O-antigen.34–36 CS2429 (waaC) is a deep rough isogenic
mutant of CS180 that lacks both the O-antigen and most of the core.
Additional isogenic mutants of CS180 used in this study include: CS2198
(waaR), CS2488 (waaO), and CS1943 (waaG) (Figure 1)35,36 (Table 1).22,24 The
E. coli strains were cultured on Luria–Bertani agar. Y. pseudotuberculosis (Y1) is
a serotype O:1a strain that lacks the virulence plasmid (pYV). The Y. pestis
strains used in this study originated from KIM5 (KIM D27), a strain in which
the pgm (pigmentation) gene has been deleted.37 These strains are avirulent
when delivered by peripheral routes of infection. KIM10-Δail is a KIM5
derivative in which the ail gene has been deleted38 and the pCD1 and pPCP1
plasmids have been cured.13,38 To simplify the nomenclature, KIM10-Δail has
been abbreviated as KIM10− throughout this manuscript. KIM10−-O+
expresses an O-antigen from Y. enterocolitica serotype O:319 and is an isogenic
derivative of KIM10−. KIM10−-core− is also an isogenic derivative of KIM10−,
in which the outer core oligosaccharides have been deleted as described below
(Table 1). The Yersinia strains were cultured on GC-based plates (Difco, Sparks,
MD, USA) supplemented with 1% haemoglobin (USB Co., Cleveland, OH,
USA). All strains of Yersinia spp. used in this study were cultured at 26 °C.
Reagents
(1) Anti-hLangerin and anti-DC-SIGN antibodies were purchased from
Pharmingen (San Diego, CA, USA). YTH71.3, a rat antibody that recognises
CEACAM1 (CD66a), CEACAM6 (CD66c) and CEACAM3 (CD66d) was
purchased from Roche (Indianapolis, IN, USA). The anti-FLAG antibody
conjugated to FITC was purchased from Sigma (St Louis, MO, USA). (2) The
following oligosaccharides and mannan were purchased from Sigma:
β-D-GlcNAc-(1→ 3)-β-D-Gal-1→OMe {(Methyl 3-O-(N-acetyl-β-D-glucosa-
minyl)-β-D-galactopyranoside, M0775}, α-NeuNAc-(2→ 3)-β-D-Gal-(1→ 4)
(α-L-Fuc-[1→ 3])-D-GlcNAc {3'-Sialyl-Lewis-X tetrasaccharide, S1782},
β-D-GlcNAc-(1→ 6)-β-D-Gal-(1→ g2057 4)-D-Glc {β 6'-GlcNAc-lactose,
A8297}, β-D-Gal-(1→ 4)-D-GlcNAc {N-Acetyl-D-lactosamine, A7791} and
β-D-Gal-(1→ 6)-D-GlcNAc {2-Acetamido-2-deoxy-6-O-(β-D-galactopyrano-
syl)-D-glucopyranose, A7916}. (3) The monosaccharides, GlcNAc and GalNAc,
were purchased from Sigma. (4) Mermaid is a DC-SIGN-like molecule
expressed by the marine nematode Laxus oneistus. The carbohydrate recogni-
tion domain of Mermaid shares both structural and functional similarity with
that of DC-SIGN.39 A recombinant form of Mermaid (His-Mermaid) was
expressed and puriﬁed as described previously.39 (5) The extracellular domain
of hLangerin tagged with the FLAG epitope used in this study was generated
and puriﬁed according to a previously described protocol for mouse
Langerin.40,41 (6) Puriﬁed core oligosaccharides from an N. gonorrhoeae lgtB
variant were used in this study because our previous data showed that the core
oligosaccharides from this bacterium, unlike E. coli K-12 core oligosaccharides,
inhibited the core oligosaccharide–hDC-SIGN interaction.14 In addition, our
unpublished data have shown that the puriﬁed core oligosaccharides from
KIM10− do not inhibit hLangerin– and hDC-SIGN–Y. pestis interactions. The
loss of the ability to inhibit these interactions is likely due to changes in
conformation generated during the puriﬁcation process. The puriﬁcation
procedures of core oligosaccharides have been described previously.14
Human cord blood LCs
hcbLCs derived from human cord blood cells were purchased from MatTek
Corporation (Ashland, MA, USA). However, the methods used to generate
these LCs are proprietary and are not available from the manufacturer. Based
on the information provided by the manufacturer, this LC line expresses
Langerin, which was conﬁrmed in Figure 5a. Although previous studies have
suggested that LCs usually do not express DC-SIGN,7 our data show that the
hcbLCs purchased from this company express a low level of DC-SIGN
(Figure 5a).
Isolation and puriﬁcation of hLCs
hLCs were obtained from healthy patients who were undergoing plastic surgery
and provided informed consent. Brieﬂy, skin biopsies were freed from fatty
tissues and split-cut with a keratome set.42 Skin slices were then incubated with
0.05% trypsin containing EDTA in Hanks buffer without Ca2+ and Mg2+ for
1 h at 37 °C. Then the epidermis was detached from the dermis using ﬁne
Figure 4 Interaction of core oligosaccharide E. coli mutants with CHO-
hLangerin cells. Internalisation of E. coli K-12 strains CS180, CS2198
(waaR), CS2488 (waaO), CS1943 (waaG) and CS2429 (waaC) (Figure 1) by
CHO and CHO-hLangerin cells was determined using the same procedures
described in Figure 2. The data presented were pooled from three
independent experiments. The data represent the means± s.e.m. N=9.
Statistical analysis was performed using one-way analysis of variance and the
Newman–Keuls test. ***Po0.001.
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Figure 5 Inhibition of hLangerin-mediated phagocytosis of Y. pestis by anti-hLangerin antibody, mannan and oligosaccharides. The expression levels of
hcbLCs and hLCs are shown in panels (a) and (c), respectively. Y. pestis KIM10− cultured at 26 °C was incubated with hcbLCs (b) and hLCs (d) for 1.5 h
and CHO-hLangerin cells for 2 h (e) in the presence or absence of puriﬁed FLAG-hLangerin, anti-CD66/-hLangerin/-hDC-SIGN antibodies, mannan, various
oligosaccharides and a DC-SIGN-like protein (His-Mermaid). The experiments with hcbLCs and hLCs were performed using antibody treatment only. All
reagents were added to the media 20min before the addition of bacteria. The concentration of each reagent used in this experiment was based on previously
published data.14–16 The phagocytosis rate of Y. pestis was determined by the recovery of bacteria following gentamicin treatment. Y. pseudotuberculosis
serotype O:1a was used as a control strain that shows core-independent invasion of CHO cells. The data presented were pooled from three independent
experiments. The data represent the means± s.e.m. N=9. Statistical analysis was performed using one-way analysis of variance and the Newman–Keuls test.
***Po0.001.
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forceps, after which it was placed in Hank’s balanced salt solution supple-
mented with 10% heat-inactivated foetal calf serum. Repeat pipetting was used
to disrupt the epidermal sheets, and single-cell suspensions were achieved with
repeat pipetting and forceful passage through sterile gauze. Consecutive density
gradient centrifugation with lymphocyte separation was used to enrich the LCs
fractions, as previously described.42 CD1a and CD207 monoclonal antibodies
were used to determine the purity or the expression levels of freshly
isolated hLCs.
Human C-type lectin transfectants
CHO-hLangerin and CHO-hDEC-205 cell lines were generated by transfecting
CHO cells cells with corresponding human C-type lectin cDNAs. Transfection
was followed by G418 (1.5mgml− 1) selection and screening for stable surface
expression, as illustrated in Figure 3a.43 CHO-NEO cells were used as a control
cell line that expresses the neomycin resistance gene only.
Adherence and phagocytosis assays
The assays for adherence and phagocytosis have been described previously.44
Brieﬂy, host cells (hcbLCs, hLCs and CHO) were plated in 24- or 96-well
plates. The cells were suspended in RPMI medium supplemented with 2%
foetal calf serum at a concentration of 4× 105 ml− 1 (hLCs at a concentration of
8× 104 ml− 1). In all, 500 μl of each of these cell suspensions was added to
24-well plates, and after the addition of 50 μl of bacterial suspensions at a
concentration of 5× 106 CFUml− 1, the cells were allowed to incubate for 2 h at
37 °C in the presence of 5% CO2.
To determine the internalisation of bacteria, gentamicin, which kills
extracellular bacteria but cannot penetrate into host cells, was added to each
well at a ﬁnal concentration of 100 μgml− 1, and the cultures were incubated
for 60min. The cells were washed twice to remove the gentamicin. The cells
were suspended in phosphate-buffered saline containing 0.5% saponin, after
which the cells were diluted and plated on Luria–Bertani or GC-based media
plates. The level of internalisation of bacteria in the host cells was calculated by
Figure 6 Puriﬁed FLAG-hLangerin and DC-SIGN-like molecules bind to Y.
pestis core oligosaccharides. Y. pestis KIM10−, KIM10−-O+, CS180 and
CS1861 were incubated with 10 μg of FITC-His-Mermaid and puriﬁed FLAG-
Langerin for 30min. The ability of FITC-His-Mermaid and Langerin to bind
the bacteria was measured using ﬂow cytometry. The ﬂuorescence intensities
of KIM10− or CS180 and KIM10−-O+ or CS1861 are represented by non-
ﬁlled and ﬁlled curves, respectively. E. coli strains CS180 and CS1861
should be regarded as positive and negative controls, respectively, as shown
previously.14,45.
Figure 7 Expression of Y. pestis O-antigen reduces pathogen dissemination and host death. (a) KIM6+ and KIM6+-O+ (O-antigen expressing) were inoculated
in mice following the procedures described in the Methods section. After 24 h, the mice were killed, and the subiliac lymph nodes were separated,
homogenised and spread on GC-base plates. The dissemination rate represents the CFU recovered from whole subiliac lymph nodes. The data presented were
pooled from three independent experiments. The data represent the means± s.e.m. N=9. Statistical analysis was performed using Student’s t-test.
***Po0.001. (b) Mouse survival in a dissemination model challenged with Y. pestis 1418 (KIM D27) or Y. pestis 1418-O+. The survival curve shows the
animal survival time from the inoculation. The data presented were pooled from three independent experiments. Statistical analysis was performed using the
log-rank test. *Po0.05.
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determining the CFU recovered from lysed cells. All experiments were
performed in triplicate, and the data are expressed as the means± s.e.m.
For the inhibition assay, puriﬁed FLAG-Langerin (100 μgml− 1), anti-
hLangerin (5 μgml− 1) antibody, anti-DC-SIGN (5 μgml− 1) antibody and
carbohydrates, including core oligosaccharides (500 μgml− 1), oligosaccharides
(500 μgml− 1), a DC-SIGN-like protein (10 μgml− 1) or mannan
(500 μgml− 1), were added 20min prior to the addition of bacteria. The
concentrations used were determined based on our preliminary data and were
selected based on the fact that, at these concentrations, the compounds exerted
no effects on the survival of bacteria or host cells, as previously shown.13,14
Determination of phagocytosis by ﬂow cytometry
The following method was used to supplement the survival-based phagocytosis
assay described above, as APCs are known to kill some phagocytosed
bacteria.13,15 Brieﬂy, the bacteria were suspended in RPMI medium containing
5- and 6-carboxyﬂuorescein diacetate succinimidyl ester (CFDA-SE; Molecular
Probes, Eugene, OR, USA) for 40min and then washed twice with RPMI to
remove the excess dye. The labelled bacteria were added to the cell cultures and
allowed to interact for 2 h. Cell cultures were washed twice to remove the
unbound bacteria. The LCs and associated bacteria were ﬁxed with 2%
paraformaldehyde. Before ﬂow cytometry, a 1:10 dilution of trypan blue
(0.4%, Sigma) was added to the ﬁxed cell cultures, and the mixture was
incubated at ambient temperature for 10min15 to quench the ﬂuorescence
from the extracellular-labelled bacteria. Trypan blue blocks ﬂuorescence but
cannot penetrate host cells. Therefore, ﬂuorescence from internalised bacteria is
not inﬂuenced by the addition of trypan blue. The rate of bacterial
internalisation was determined by comparing the intensity of ﬂuorescent cells
infected with the various bacteria. Greater the ﬂuorescence intensity indicates
that more bacteria were phagocytosed by the LCs.
Binding of FITC-conjugated His-Mermaid and puriﬁed
FLAG-Langerin to bacteria
Mermaid is secreted by L. oneistus onto the posterior, bacteria-associated region
of this marine nematode. The interaction of Mermaid with bacteria is thought
to induce symbiont aggregation.39 FITC-conjugated His-Mermaid (FITC-His-
Mermaid) was generated using the FITC Labeling Kit (Calbiochem Corp., San
Diego, CA, USA) according to the manufacturer’s instructions and as described
previously.14
E. coli CS180/CS1861 and Y. pestis KIM10−/KIM10−-O+, suspended in
phosphate-buffered saline at OD600= 0.02, were incubated with FITC-His-
Mermaid or puriﬁed FLAG-Langerin at a concentration of 20 μgml− 1 for
30min. For FITC-His-Mermaid binding, the bacteria were washed once with
phosphate-buffered saline before ﬂow cytometry analysis. For Langerin binding,
FITC-conjugated anti-FLAG antibody was added to the bacterial suspensions
after one wash. The binding of FITC-His-Mermaid and puriﬁed FLAG-
Langerin to the bacteria were measured based on ﬂuorescence intensity using
ﬂow cytometry.
In vivo dissemination assay
The in vivo dissemination assay is similar to an assay we previously developed.9
KIM6+ and KIM6+-O+ (expressing O-antigen) were suspended in phosphate-
buffered saline at OD600= 1.5. In all, 50 μl of the Yersinia suspension was
injected into both of the hind paws of mice. The mice were also injected
intravenously with ampicillin at a ﬁnal concentration of 50 μg g− 1 body weight
to maintain the plasmid-based expression of O-antigen. The mice were killed,
and the subiliac lymph nodes were isolated 24 h post-injection. The isolated
buboes were then homogenised and lysed with 1% Triton X-100 to release the
bacteria prior to plating onto agar plates containing ampicillin. The total
isolated CFU of the subiliac lymph nodes per mouse was deﬁned as the
dissemination rate.
Animal challenging
Y. pestis 1418 (KIM D27) and its O-antigen-expressing derivative Y. pestis
1418-O+ were inoculated at OD600= 0.2 in a similar manner to that described
for the in vivo dissemination assay. The death of the mice was recorded every
12 h up to 156 h post-infection.
Statistical analyses
All statistical analyses were conducted using the Prism software, version 6
(Graph Pad, San Diego, CA, USA). Statistical analyses for the in vitro studies
were performed using one-way analysis of variance and Newman–Keuls test.
Statistical analyses for the in vivo studies were performed using Student's t-test.
Survival group comparison was performed via log-rank test using Kaplan–
Meier analysis. Po0.05 was considered as the threshold for statistically
signiﬁcant differences.
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